MVX-ONCO-1 phase 1 final results of the first personalized cell-based immunotherapy using cell encapsulation technology

被引：10
作者：
Mach, N. [1 ]
Vernet, R. [1 ]
Belkouch, M-C. [1 ]
Luy, P. [1 ]
Ancrenaz, V. [1 ]
Teta, P. [1 ]
Blazek, N. [1 ]
Grandjean, N. [1 ]
Wasem, J. [1 ]
Grogg, J. [2 ]
Perez, T. [2 ]
Migliorini, D. [1 ]
机构：
[1] HUG, Oncol, Geneva, Switzerland
[2] MaxiVAX SA, Clin Operat, Geneva, Switzerland
来源：
ANNALS OF ONCOLOGY | 2016年 / 27卷
关键词：
D O I：
10.1093/annonc/mdw378.12
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1058P
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Assessing the impact of AGS-004, a dendritic cell-based immunotherapy, and vorinostat on persistent HIV-1 Infection
    Gay, Cynthia L.
    Kuruc, Joann D.
    Falcinelli, Shane D.
    Warren, Joanna A.
    Reifeis, Sarah A.
    Kirchherr, Jennifer L.
    James, Katherine S.
    Dewey, Morgan G.
    Helms, Alyson
    Allard, Brigitte
    Stuelke, Erin
    Gamble, Alicia
    Plachco, Ana
    Gorelick, Robert J.
    Eron, Joseph J.
    Hudgens, Michael
    Garrido, Carolina
    Goonetilleke, Nilu
    DeBenedette, Mark A.
    Tcherepanova, Irina Y.
    Nicolette, Charles A.
    Archin, Nancie M.
    Margolis, David M.
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [32] PD-L1 expression is a predictive biomarker for CIK cell-based immunotherapy in postoperative patients with breast cancer
    Zhou, Zi-Qi
    Zhao, Jing-Jing
    Pan, Qiu-Zhong
    Chen, Chang-Long
    Liu, Yuan
    Tang, Yan
    Zhu, Qian
    Weng, De-Sheng
    Xia, Jian-Chuan
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7 (01):
  • [33] Treatment of inoperable pancreatic carcinoma using a cell-based local chemotherapy:: results of a phase I/II clinical trial
    Salmons, B
    Löhr, M
    Günzburg, WH
    JOURNAL OF GASTROENTEROLOGY, 2003, 38 : 78 - 84
  • [34] Survival with AGS-003, an autologous dendritic cell-based immunotherapy, in combination with sunitinib in unfavorable risk patients with advanced renal cell carcinoma (RCC): Phase 2 study results
    Amin, Asim
    Dudek, Arkadiusz Z.
    Logan, Theodore F.
    Lance, Raymond S.
    Holzbeierlein, Jeffrey M.
    Knox, Jennifer J.
    Master, Viraj A.
    Pal, Sumanta K.
    Miller, Wilson H., Jr.
    Karsh, Lawrence I.
    Tcherepanova, Irina Y.
    DeBenedette, Mark A.
    Williams, W. Lee
    Plessinger, Douglas C.
    Nicolette, Charles A.
    Figlin, Robert A.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2015, 3
  • [35] CHARACTERIZATION OF ANTIBODIES AGAINST BTN2A1 FOR Vδ2+ gd T CELL-BASED TUMOR IMMUNOTHERAPY
    Chan, Kok Fei
    Ostrouska, Simone
    Prasad, Ranjeeta
    Kurtov, Daria
    Hammet, Andrew
    Rigau, Marc
    Uldrich, Adam
    Behren, Andreas
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A204 - A204
  • [36] MUC1-Targeted Dendritic Cell-Based Vaccine Immunotherapy in Patients with Standard Treatments-Refractory Non-Small-Cell Lung Cancer
    Teramoto, Koji
    Hanaoka, Jun
    Tezuka, Noriaki
    Daigo, Yataro
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S208 - S208
  • [37] Clinical and Immunologic Evaluation of Dendritic Cell-Based Immunotherapy in Combination With Gemcitabine and/or S-1 in Patients With Advanced Pancreatic Carcinoma
    Kimura, Yukino
    Tsukada, Jun
    Tomoda, Takeshi
    Takahashi, Hidenori
    Imai, Kazuhiro
    Shimamura, Kanae
    Sunamura, Makoto
    Yonemitsu, Yoshikazu
    Shimodaira, Shigetaka
    Koido, Shigeo
    Homma, Sadamu
    Okamoto, Masato
    PANCREAS, 2012, 41 (02) : 195 - 205
  • [38] A High Throughput Cell-Based Screen Assay for LINE-1 ORF1p Expression Inhibitors Using the In-Cell Western Technique
    Kou, Yanni
    Wang, Shujie
    Ma, Yanjie
    Zhang, Ning
    Zhang, Zixiong
    Liu, Qian
    Mao, Yang
    Zhou, Rui
    Yi, Dongrong
    Ma, Ling
    Zhang, Yongxin
    Li, Quanjie
    Wang, Jing
    Wang, Jinhui
    Zhou, Xile
    He, Chunnian
    Ding, Jiwei
    Cen, Shan
    Li, Xiaoyu
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [39] Dendritic cell-based immunotherapy in combination with programmed cell death 1 blockade reduced established tumors by activating Th-1 type immune responses in a murine hepatocellular carcinoma model
    Hayashi, Eiichi
    Eguchi, Junichi
    Sakaki, Masashi
    Doi, Hiroyoshi
    Oomori, Risa
    Kajiwara, Atsushi
    Yoshida, Hitoshi
    Ishii, Shigeaki
    Hiroishi, Kazumasa
    Imawari, Michio
    CANCER RESEARCH, 2014, 74 (19)
  • [40] Development of a Cell-Based AAV9 Vector Potency Assay for the GAN Phase 1 Clinical Trial
    Bailey, Rachel M.
    Zaric, Violeta
    Grieger, Joshua C.
    Samulski, R. Jude
    Gray, Steven J.
    MOLECULAR THERAPY, 2017, 25 (05) : 125 - 126
12345